Dr. Andrew Law

Dr. Andrew Law is an experienced clinical research professional currently serving as Senior Director of Clinical Research at Hemab Therapeutics since June 2024. Prior roles include Global Medical Director at Alexion Pharmaceuticals, where Dr. Law was instrumental in the clinical development of Andexanet, and Associate Director of Medical Affairs, leading its launch in the UK and Ireland. Dr. Law's previous experience encompasses various leadership positions in medical affairs and clinical development at companies such as TMC Pharma Services, Shire, Baxalta, and Baxter International. Dr. Law holds a Bachelor of Medicine and Surgery, and a BSc in Neuroscience from the University of Bristol.